ANNEX IISupplementary provisions
ANNEX II In Part D of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added: No. Common Name, Identification Numbers IUPAC Name Purity ( 1 ) Date of approval Expiration of approval Specific provisions ‘33 Bacillus amyloliquefaciens AH2 n.a. The nominal content of Bacillus amyloliquefaciens AH2 in the technical product and formulation is 1,0 × 10 11 CFU/L (range 7x10 10 – 7x10 11 ). No relevant impurities 27 September 2021 27 September 2036 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Bacillus amyloliquefaciens AH2 and in particular Appendices I and II thereof, shall be taken into account. ( 1 ) Further details on the identity and the specification of the active substance are provided in the renewal report.’